SARS-CoV-2: From the pathogenesis to potential anti-viral treatments - 19/03/21
, Maryam Zinatizadeh c, Mohammad Hadi Yousefi d, e, Nima Rezaei f, g, h, ⁎
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Introduction |
The world is witnessing the spread of one of the members of Coronaviruses (CoVs) family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the 21st century. Considering the short time spent after its prevalence, limited information is known about the effect of the virus mechanism on different organs of the body; meanwhile the lack of specific treatment and vaccine for this virus has exposed millions of people to a big challenge.
Areas covered |
The review article aims to describe the general and particular characteristics of CoVs, their classification, genome structure, host cell infection, cytokine storm, anti-viral treatments, and inhibition of COVID-19-related ER-mitochondrial stress. In addition, it refers to drugs such as Chloroquine/Hydroxychloroquine, Lopinavir/Ritonavir, darunavir, ribavirin, remdesivir, and favipiravir, which have undergone clinical trials for coronavirus disease 2019 (COVID-19) treatment. This analysis was derived from an extensive scientific literature search including Pubmed, ScienceDirect, and Google Scholar performed.
Expert opinion |
The effectiveness rate and complications of these drugs can reveal new insights into the potential therapeutic goals for the disease. Moreover, lifestyle change can effectively prevent SARS-CoV-2 infection.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | The 21st century is currently facing the SARS-CoV-2 pandemic. |
• | During evolution, SARS-CoV-2 have evolved strategies to escape immune responses by targeting ER and mitochondria. |
• | COVID-19-related ER-mitochondrial stress is a major player in the promoting of cytokine storms and ARDS. |
• | Non-viral compounds as a new therapeutic strategy for inhibiting ER-mitochondrial stress related to COVID-19. |
• | Another treatment strategy for COVID-19 is the concomitant use of antiviral drugs with non-viral compounds. |
Keywords : Anti-viral treatments, Cytokine storm, MERS, Pathogenesis, SARS-CoV-2, SARS
Plan
Vol 137
Article 111352- mai 2021 Retour au numéro
Article précédent
- Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression
- Xiaoxu Wang, Yafan Li, Lingjun Wu, Shiju Xiao, Yunrun Ji, Yong Tan, Chunyan Jiang, Guangzhong Zhang
- Role of circular RNAs in colorectal tumor microenvironment
- Jasni Viralippurath Ashraf, Varun Sasidharan Nair, Reem Saleh, Eyad Elkord
Bienvenue sur EM-consulte, la référence des professionnels de santé.